AIM
XPH icon

Anchor Investment Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Anchor Investment Management’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-146
Closed -$6.35K – 830
2017
Q4 		$6.35K Hold
146
– – ﹤0.01% 687
2017
Q3 		$6.21K Buy
+146
New +$6.19K ﹤0.01% 671

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
AL
Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return

Anchor Investment Management's XPH Position: Q1 2018 in Review

Anchor Investment Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2018, closing a stake of 146 shares — an estimated $6.35K sold.

Anchor Investment Management first reported a position in XPH in Q3 2017 and held it in 2 quarters. The position peaked at $6.35K in Q4 2017. 75 funds tracked by Wall St. Rank hold XPH as of Q1 2018.

  • Anchor Investment Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
  • Anchor Investment Management sold 146 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2018, an estimated $6.35K.
  • Anchor Investment Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2017 and held it in 2 quarters.
  • Anchor Investment Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $6.35K in Q4 2017.
  • 75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2018.

Based on Anchor Investment Management's 13F filing for Q1 2018, filed 3 Jan 2024.